IRIS
PALAZZUOLI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.019
EU - Europa 3.089
AS - Asia 913
SA - Sud America 116
AF - Africa 14
OC - Oceania 6
Totale 8.157
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.010
GB - Regno Unito 894
IE - Irlanda 578
CN - Cina 453
SE - Svezia 331
UA - Ucraina 285
SG - Singapore 274
IT - Italia 259
RU - Federazione Russa 233
DE - Germania 167
FR - Francia 132
VN - Vietnam 122
BR - Brasile 107
FI - Finlandia 99
BE - Belgio 27
CZ - Repubblica Ceca 19
NL - Olanda 16
ES - Italia 11
TR - Turchia 11
HK - Hong Kong 8
IN - India 8
GR - Grecia 7
CA - Canada 5
CI - Costa d'Avorio 5
AU - Australia 4
BD - Bangladesh 4
IQ - Iraq 4
NO - Norvegia 4
PE - Perù 4
AT - Austria 3
AZ - Azerbaigian 3
BG - Bulgaria 3
IL - Israele 3
LA - Repubblica Popolare Democratica del Laos 3
LT - Lituania 3
NP - Nepal 3
UZ - Uzbekistan 3
AL - Albania 2
AR - Argentina 2
DK - Danimarca 2
EC - Ecuador 2
EG - Egitto 2
GE - Georgia 2
IM - Isola di Man 2
JO - Giordania 2
JP - Giappone 2
KE - Kenya 2
LV - Lettonia 2
MX - Messico 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
RO - Romania 2
RS - Serbia 2
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
DZ - Algeria 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
LU - Lussemburgo 1
MA - Marocco 1
MY - Malesia 1
NG - Nigeria 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 8.157
Salva come PNG Salva come JPEG
Città #
Southend 792
Dublin 571
Fairfield 563
Ashburn 351
Chandler 326
Woodbridge 289
Ann Arbor 277
Houston 262
Jacksonville 229
Seattle 229
Santa Clara 228
Wilmington 222
Cambridge 183
Dong Ket 121
Beijing 117
Singapore 108
Princeton 96
Nanjing 80
Siena 77
New York 52
Dearborn 51
Helsinki 49
Shanghai 43
San Nicola la Strada 40
Boardman 39
Brussels 27
Moscow 27
San Mateo 26
Los Angeles 24
Lancaster 22
Shenyang 21
Council Bluffs 20
Düsseldorf 20
Jiaxing 16
Kunming 16
Munich 16
Nanchang 16
Hebei 15
Rome 15
San Diego 15
Florence 14
Changsha 13
Jinan 12
Phoenix 12
The Dalles 12
Tianjin 12
London 11
Brno 10
Menlo Park 10
Málaga 10
Portsmouth 9
Falls Church 8
Norwalk 8
Berlin 7
Hefei 7
Izmir 7
Milan 7
Nuremberg 7
Olomouc 7
Washington 7
Zhengzhou 7
Hong Kong 6
Lauterbourg 6
Mestre 6
Naples 6
Stockholm 6
Tappahannock 6
Venezia 6
Abidjan 5
Guangzhou 5
Ningbo 5
São Paulo 5
Toronto 5
Auburn Hills 4
Cagliari 4
Frankfurt am Main 4
Fremont 4
Fuzhou 4
Lanzhou 4
Redwood City 4
Voghera 4
Baku 3
Belo Horizonte 3
Chiswick 3
Collecorvino 3
Dallas 3
Detroit 3
Espoo 3
Falkenstein 3
Gießen 3
Goiânia 3
Guarulhos 3
Hangzhou 3
Lima 3
Nijkerk 3
Oslo 3
Pescara 3
San Francisco 3
Sofia 3
Taizhou 3
Totale 6.044
Salva come PNG Salva come JPEG
Nome #
B-type natriuretic peptide levels predict extent and severity of coronary disease in non-ST elevation coronary syndromes and normal left ventricular systolic function. 251
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 240
B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevation coronary syndromes with preserved systolic function 235
Anemia correction by erythropoietin reduces BNP levels, hospitalization rate, and NYHA class in patients with cardio-renal anemia syndrome. 218
Natriuretic peptides in heart failure: where we are, where we are going. 211
Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure 208
Quantitative evaluation of microvessels in Behcet's disease 206
Prognostic significance of hyperuricemia in patients with acute heart failure 199
H pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease 198
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 190
Different diuretic dose and response in acute decompensated heart failure: Clinical characteristics and prognostic significance 184
Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial 174
Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure. 174
Role of BNP and echo measurement for pulmonary hypertension recognition in patients with interstitial lung disease: An algorithm application model 173
Comparison of neutrophil gelatinase-associated lipocalin versus B-type natriuretic peptide and cystatin C to predict early acute kidney injury and outcome in patients with acute heart failure 173
Different trajectories and significance of B-type natriuretic peptide, congestion and acute kidney injury in patients with heart failure 172
The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questions 167
Genetic influence in antithrombotic actions of atorvastatin in hypercholesterolaemia 165
Kidney disease in heart failure: the importance of novel biomarkers for type 1 cardio-renal syndrome detection 165
Cross-sectional study: CagA-positive Helicobacter pylori infection, acute coronary artery disease and systemic levels of B-type natriuretic peptide 161
Loop Diuretics Strategies in Acute Heart Failure: From Clinical Trials to Practical Application 158
null 155
Natriuretic peptides and NGAL in heart failure: does a link exist? 155
The impact of infarct size on regional and global left ventricular systolic function: a cardiac magnetic resonance imaging study 154
Patients with cardiorenal syndrome revealed increased neurohormonal activity, tubular and myocardial damage compared to heart failure patients with preserved renal function 151
Clinical impact of BNP and other emerging biomarkers in heart failure evaluation and management 148
The role of natriuretic peptides for the diagnosis of left ventricular dysfunction 147
Diagnostic utility of contemporary echo and BNP assessment in patients with acute heart failure during early hospitalization 147
Molecular dysfunction and phenotypic derangement in diabetic cardiomyopathy 145
Heart failure: pathophysiology and clinical picture. 143
Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure 140
Left ventricular hypertrophy differences in male professional runners and in young patients suffering from mild hypertension 133
null 133
The potential role of natriuretic peptides in acute coronary syndrome stratification 127
null 122
Current therapeutic strategies in cardiorenal syndrome 121
null 120
Definizione di pattern videocapillaroscopici (VCS) di normalità nel microcircolo cutaneo. Stratificazione secondo l'età 117
null 111
Peptide natriuretico di tipo B ed ecocardiografia Doppler nella diagnosi di scompenso cardiaco: Metodiche alternative o complementari? [B-type natriuretic peptide and Doppler echocardiography in the diagnosis of heart failure: alternative or complementary tools?] 110
Dyslipidemias and fibrinolysis. 106
Relation of plasma brain natriuretic peptide levels in non-ST-elevation coronary disease and preserved systolic function to number of narrowed coronary arteries 105
null 105
Left ventricular diastolic function improvement by carvedilol therapy in advanced heart failure 103
null 100
From gene mutations to biomechanical abnormalities and electrophysiological remodeling in hypertrophic cardiomyopathy: exploring the translational approach. 94
Pulmonary hypertension: a correct diagnosis for a suitable therapy in scleroderma patients 74
Additional value of Galectin-3 to BNP in acute heart failure patients with preserved ejection fraction 74
Chronic kidney disease and worsening renal function in acute heart failure: different phenotypes with similar prognostic impact? 73
Clinical impact of oral antidiabetic medications in heart failure patients 72
A multidisciplinary approach in neurofibromatosis 1 66
Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction 65
Infection by CagA-positive Helicobacter pylori strains in patients with ischemic heart disease: prevalence and association with exercise-induced electrocardiographic abnormalities. 59
The prognostic combined role of B-type natriuretic peptide, blood urea nitrogen and congestion signs persistence in patients with acute heart failure 54
Combined BNP and Echocardiographic assessment in interstitial lung disease for pulmonary hypertension detection 53
Arterial hypertension and atrial fibrillation: Standard and advanced echocardiography from diagnosis to prognostication 51
Effects of metolazone administration on congestion, diuretic response and renal function in patients with advanced heart failure 46
Pulmonary congestion assessment in heart failure: traditional and new tools 43
Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: Comparison with high cardiovascular risk population (Vascular Health and Risk Management (2008) 4, 4 (877-883)) 36
Sex-related differences in chronic heart failure 34
Structural and Hemodynamic Changes of the Right Ventricle in PH-HFpEF 30
Usefulness of combined ultrasound assessment of E/e' ratio, pulmonary pressure, and cava vein status in patients with acute heart failure 24
Myocardial 123I-metaiodobenzylguanidine imaging in hypertension and left ventricular hypertrophy 23
Right ventricular dysfunction in chronic heart failure: Clinical laboratory and echocardiographic characteristics. (the RIVED-CHF registry) 23
Are HFpEF and HFmrEF So Different? The Need to Understand Distinct Phenotypes 22
Additional value of Galectin-3 respect to BNP in acute heart failure patients with preserved ejection fraction 13
The role of fibrosis and inflammation for response and outcome prediction in candidates to cardiac resynchronization therapy: is response the right answer? 13
Cardio-renal syndrome revealed increased neurohormonal activity, tubular and myocardial damage respect to heart failure patients with preserved renal function 12
Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF 12
Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care 12
Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure 11
Chronotropic incompetence across heart failure categories 10
Continuous versus intermittent loop diuretics infusion dosing in acute heart failure: effects on renal function, outcome and BNP levels 10
Additional value of Galectin-3 to BNP in acute heart failure patients with preserved ejection fraction 10
The role of fibrosis, inflammation, and congestion biomarkers for outcome prediction in candidates to cardiac resynchronization therapy: is “response” the right answer? 9
Contemporary assessment of lung ultrasound, BNP and echocardiography for outcome prediction in patients with decompensated heart failure 8
Circulating Biomarkers in Pulmonary Arterial Hypertension: An Update 7
The predictive value of plasma biomarkers in discharged heart failure patients: the role of plasma BNP 7
Integrated Cardiorespiratory Rehabilitation and Its Impact on Cardio-Renal-Metabolic Profile After Cardiac Surgery 7
Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction 7
Clinical impact of renal dysfunction in heart failure 6
Implementation of guideline‐directed medical therapy in patients with heart failure with reduced ejection fraction (OpTIMa‐HF Registry) 6
Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy 6
Transient versus persistent worsening renal function during hospitalization in acute heart failure: different phenotypes for different outcome 5
Multi-biomarkers laboratory strategy for outcome prediction in patients with severe systolic dysfunction submitted to CRT 4
Dynamic variation of renal function and novel or old HF biomarkers (ST2, Galectin 3, NT-proBNP) and response to cardiac resynchronization therapy (CRT) 4
The Treatment of Heart Failure in Patients with Chronic Kidney Disease: Doubts and New Developments from the Last ESC Guidelines 4
Different neurohormonal and inflammatory pattern in acute CRS respect to AHF patients with preserved renal function 4
Contemporary assessment of lung ultrasound, bnp and echocardiography predicts outcome in patients with acute heart failure independently to systolic dysfunction 4
The relevance of specific heart failure outpatient programs in the COVID era: An appropriate model for every disease 3
Laboratory and Metabolomic Fingerprint in Heart Failure with Preserved Ejection Fraction: From Clinical Classification to Biomarker Signature 3
The assessment, interpretation and implementation of lung ultrasound examinations in Heart Failure: Current evidence and gaps in knowledge 3
Plasma Neuthrophil Gelatinase associated Lipocalin (NGAL) predict worsening renal function and outcome in patients with acute decompensated heart failure 2
Totale 8.338
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.247
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.247
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020314 0 0 0 0 0 0 0 0 0 181 46 87
2020/20211.094 41 122 37 81 80 98 45 160 67 103 82 178
2021/2022677 36 71 32 77 63 25 29 25 39 75 67 138
2022/20231.069 64 100 143 138 118 196 24 83 88 20 35 60
2023/2024933 47 24 103 45 21 239 321 21 6 26 16 64
2024/20251.236 41 74 147 111 248 174 115 108 181 37 0 0
Totale 8.338